Clinical Trial Update: Safety and Efficacy of Oncoxin Plus Surafineb in Hepatocellular Carcinoma [Phase 2, Phase 3]

View source ↗

Summary

This report describes a Phase 2/Phase 3 trial evaluating the combination of Oncoxin and Surafineb in hepatocellular carcinoma, with the current status not speci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• ONCOXIN
• Surafineb

Snippet

Sponsor: Clinical Research Organization, Dhaka, Bangladesh | Conditions: Quality of Life | Phase 2, Phase 3 | Status: UNKNOWN